News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Elsevier Oncology – Safety, Pharmacokinetics, and Efficacy of Asandeutertinib in Advanced EGFR-mutated NSCLC
Photo: Depositphotos
Jun 27, 2025, 07:02

Elsevier Oncology – Safety, Pharmacokinetics, and Efficacy of Asandeutertinib in Advanced EGFR-mutated NSCLC

Elsevier Oncology posted on LinkedIn:

“From the Journal of Thoracic Oncology’s Editor’s Choice collection: compelling phase 1 data in NSCLC therapy.
Han B et al. present findings on Asandeutertinib’s safety, pharmacokinetics, and efficacy in advanced EGFR-mutated NSCLC.”

Title: Safety, Pharmacokinetics, and Efficacy of Asandeutertinib in Advanced EGFR-mutated NSCLC: A Phase 1 Dose-Escalation and Dose-Expansion Study

Authors: Baohui Han, Jie Liu, Lin Wu, Yanqiu Zhao, Wei Zhang, Bolin Chen, Jianbo He, Jianhua Shi, Yanqing Liu, Zhe Zhang, Xiugui Chen, Yusheng Wu

Read The Full Article.

Elsevier Oncology - Safety, Pharmacokinetics, and Efficacy of Asandeutertinib in Advanced EGFR-mutated NSCLC

More posts featuring Lung Cancer.

Baohui Han Bolin Chen Elsevier Oncology Jianbo He Jianhua Shi Jie Liu Journal of Thoracic Oncology Lin Wu Lung cancer NSCLC Wei Zhang Xiugui Chen Yanqing Liu Yanqiu Zhao Yusheng Wu Zhe Zhang
Special Coverage
Blog
Jun 27, 2025, 07:03
Michael Jefford: Great Meeting of the MASCC Survivorship Study Group
Blog
Jun 27, 2025, 07:02
Elsevier Oncology - Safety, Pharmacokinetics, and Efficacy of Asandeutertinib in Advanced EGFR-mutated NSCLC
Blog
Jun 27, 2025, 06:53
LUNGevity Foundation - Committed to Cachexia: A Decade of LUNGevity Research
Blog
Jun 27, 2025, 06:52
Register for the 42nd National Oncology Conference - Association of Cancer Care Centers
Career
Jun 27, 2025, 06:51
William Pirl Joined MSKCC as the New Chair for the Department of Psychiatry and Behavioral Sciences
Blog
Jun 27, 2025, 06:44
Caitlin Delaney: Today is Rare Cancers Awareness Day!
Blog
Jun 27, 2025, 06:40
Katy Rezvani Gave One of the 2025 Susan Swerling Lecture on NK Cell Therapy at Dana-Farber Cancer Institute
Blog
Jun 27, 2025, 06:39
Lisa A. Lacasse: The Cancer Drug Parity Act Would Equalize Out-of-pocket Costs for Cancer Drugs
Blog
Jun 27, 2025, 06:33
Childhood Cancer International - Sara Trinidad’s Journey from Leukemia Survivor to Latin American Cancer Advocate
Blog
Jun 27, 2025, 06:29
MinhTri Nguyen: I Hope That Our Collective Thoughts May Be Helpful to Up-and-Coming, New, or Early Career Oncologists and Hematologist
Blog
Jun 27, 2025, 06:25
The 11th edition of the SIOG Advanced Course in Treviso Opened with Energy to Spare
Blog
Jun 27, 2025, 06:22
Join the International Lung Cancer Survivorship Conference on Sep 26 and 27 - LUNGevity Foundation